Algeria vs Jamaica: HIV/AIDS deaths averted by antiretroviral therapy
Algeria
1,007 deaths
in 2024
Jamaica
1,044 deaths
in 2022
Algeria rank
73rd
Jamaica rank
72nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Algeria
- Jamaica
How they compare
Jamaica currently reports 1,044 deaths against 1,007 deaths in Algeria, a difference of 37 deaths.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was Jamaica ahead.
Algeria ranks 73rd and Jamaica ranks 72nd of 157 countries.
Across the 4 decades both report, Algeria averaged higher in 1 and Jamaica in 3.
Head to head by decade
| Decade | Algeria | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.15 deaths | 0 deaths | 4.15 deaths | Algeria |
| 2000s | 78.66 deaths | 310 deaths | 231.34 deaths | Jamaica |
| 2010s | 458.68 deaths | 1,136 deaths | 677.82 deaths | Jamaica |
| 2020s | 848.41 deaths | 1,127 deaths | 278.25 deaths | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Algeria or Jamaica?
- Jamaica, at 1,044 deaths against 1,007 deaths in Algeria as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Algeria and Jamaica?
- 37 deaths, with Jamaica ahead.
- How many years of comparable data are there for Algeria and Jamaica?
- 33 years are reported by both, from 1990 to 2022.
- How do Algeria and Jamaica rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Algeria ranks 73rd and Jamaica ranks 72nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.